Dennis Hom
2022
In 2022, Dennis Hom earned a total compensation of $466.9K as Former Chief Financial Officer at Sagimet Biosciences.
Compensation breakdown
| Non-Equity Incentive Plan | $109,351 |
|---|---|
| Salary | $357,473 |
| Other | $68 |
| Total | $466,892 |
Hom received $357.5K in salary, accounting for 77% of the total pay in 2022.
Hom also received $109.4K in non-equity incentive plan and $68 in other compensation.
Rankings
In 2022, Dennis Hom's compensation ranked 4,400th out of 5,625 executives tracked by ExecPay. In other words, Hom earned more than 21.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,400 out of 5,625 | 22nd |
Division Manufacturing | 2,474 out of 3,053 | 19th |
Major group Chemicals And Allied Products | 1,186 out of 1,380 | 14th |
Industry group Drugs | 1,113 out of 1,281 | 13th |
Industry Pharmaceutical Preparations | 806 out of 927 | 13th |
Source: SEC filing on April 18, 2024.
Hom's colleagues
We found three more compensation records of executives who worked with Dennis Hom at Sagimet Biosciences in 2022.